Eureka Therapeutics, Inc. — US29869R1095
Source record · Eureka Therapeutics, Inc. — US29869R1095
- ISIN
- US29869R1095
- Issuer LEI
- 549300XW368SBE7KX822
- Issuer
- Eureka Therapeutics, Inc.
- Prefix
- US
- Country
- United States
- National code
- 29869R109
- Check digit
- 5 (verifies)
- CUSIP
- 29869R109
- Handle
- #://US29869R1095
- Edition address
- web+usd://isin-us29869r1095
- GTIN
- 29823424789178
Source · https://mapping.gleif.org/api/v2/isin-lei?page%5Bnumber%5D=1&page%5Bsize%5D=1
Retrieved · 2026-10-20T05:54:13.982Z
ISIN US29869R1095 edition: identity from GLEIF/ANNA (CC0); no valuation or affiliation implied. CUSIP 29869R109 is derived from the ISIN itself.